Autism Spectrum Disorder Trial, Recruiting NCT07400484 Sponsor: Chen Li Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07400484
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are 3 years old or older, but younger than 5 years old at the time of enrollment
  • Children who have been diagnosed with Autism Spectrum Disorder (ASD) by two specialist doctors (developmental behavioral pediatricians or child psychiatrists at a senior level or above), where the diagnosis meets the ICD-11 international diagnostic guidelines for ASD

Who may not be able to join:

  • Children who have been diagnosed with, or show signs of, a genetic condition linked to ASD (for example, Rett syndrome)
  • Children who have a medical or neurological condition that affects their growth, development, or thinking ability (for example, a brain infection, epilepsy, or a heart condition present from birth)
  • Children who have a sensory impairment, such as a vision or hearing loss
  • Children who were born weighing less than 2,000 grams, or who were born before 37 weeks of pregnancy
  • Children who have been adopted
  • Children whose parents or guardians are not willing to sign the consent form for the study
  • Children who the research team considers unsuitable for the study for other reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Li Chen, doctor, Children's Hospital of Chongqing Medical University

Phone: 13677620103

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chen Li
Registry
ClinicalTrials.gov
Start date
18 December 2025
Est. completion
31 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

N-CAD; fNIRS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov